Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1461, 2004-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gemifloxacin offers advantages over clarithromycin for AECB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
Access to resources
Recommend
Gemifloxacin offers advantages over clarithromycin for AECB
Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. :
Angiotensin II receptor antagonists have similar efficacy
Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. :
Moxifloxacin a better option for AECB than levofloxacin?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 300, 2001-01 ,pp. :
Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. :